These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
459 related articles for article (PubMed ID: 27044796)
81. A survey of peritonitis and exit-site and/or tunnel infections in Japanese children on PD. Hoshii S; Wada N; Honda M; Pediatr Nephrol; 2006 Jun; 21(6):828-34. PubMed ID: 16518629 [TBL] [Abstract][Full Text] [Related]
82. An integrated critique of the efficacy of topical mupirocin in preventing catheter-related Staphylococcus aureus infections in peritoneal dialysis clients. Pratt O CANNT J; 2002; 12(1):20-8. PubMed ID: 11979650 [TBL] [Abstract][Full Text] [Related]
83. Emergence of mupirocin-resistant Staphylococcus aureus in chronic peritoneal dialysis patients using mupirocin prophylaxis to prevent exit-site infection. Annigeri R; Conly J; Vas S; Dedier H; Prakashan KP; Bargman JM; Jassal V; Oreopoulos D Perit Dial Int; 2001; 21(6):554-9. PubMed ID: 11783763 [TBL] [Abstract][Full Text] [Related]
84. Fungal peritonitis in the Standardizing Care to Improve Outcomes in Pediatric End Stage Renal Disease (SCOPE) Collaborative. Munshi R; Sethna CB; Richardson T; Rodean J; Al-Akash S; Gupta S; Neu AM; Warady BA Pediatr Nephrol; 2018 May; 33(5):873-880. PubMed ID: 29313137 [TBL] [Abstract][Full Text] [Related]
85. Effect of a silver device in preventing catheter-related infections in peritoneal dialysis patients: silver ring prophylaxis at the catheter exit study. Pommer W; Brauner M; Westphale HJ; Brunkhorst R; Krämer R; Bundschu D; Höffken B; Steinhauer HB; Schümann E; Lüttgen FM; Schillinger-Pokorny E; Schaefer F; Wende R; Offner G; Näther S; Osten B; Zimmering M; Ehrich JH; Kehn M; Mansmann U; Grosse-Siestrup C Am J Kidney Dis; 1998 Nov; 32(5):752-60. PubMed ID: 9820444 [TBL] [Abstract][Full Text] [Related]
86. Nasal mupirocin prevents Staphylococcus aureus exit-site infection during peritoneal dialysis. Mupirocin Study Group. J Am Soc Nephrol; 1996 Nov; 7(11):2403-8. PubMed ID: 8959632 [TBL] [Abstract][Full Text] [Related]
87. Peritoneal Dialysis-Related Infection Rates and Outcomes: Results From the Peritoneal Dialysis Outcomes and Practice Patterns Study (PDOPPS). Perl J; Fuller DS; Bieber BA; Boudville N; Kanjanabuch T; Ito Y; Nessim SJ; Piraino BM; Pisoni RL; Robinson BM; Schaubel DE; Schreiber MJ; Teitelbaum I; Woodrow G; Zhao J; Johnson DW Am J Kidney Dis; 2020 Jul; 76(1):42-53. PubMed ID: 31932094 [TBL] [Abstract][Full Text] [Related]
88. Improved Outcome of Enteric Peritonitis in Peritoneal Dialysis Patients Aged 50 Years and Older with Temporary Discontinuation of Peritoneal Dialysis and Intravenous Meropenem. Abrahams AC; Rüger W; Ter Wee PM; van Ittersum FJ; Boer WH Perit Dial Int; 2017; 37(3):298-306. PubMed ID: 28096441 [TBL] [Abstract][Full Text] [Related]
89. Cefazolin-gentamicin versus taurolidine-citrate for the prevention of infection in tunneled central catheters in hemodialysis patients: A quasi-experimental trial. Bueloni TNV; Marchi D; Caetano C; de Souza Cavalcante R; Mendes Amaral ML; Ponce D Int J Infect Dis; 2019 Aug; 85():16-21. PubMed ID: 31102823 [TBL] [Abstract][Full Text] [Related]
90. [Importance of exit site care as peritonitis prophylaxis: experience in our centre]. Conde Rivera O; Santos Nores J; Borrajo Prol M; Pérez Melón C Nefrologia; 2010; 30(5):589-91. PubMed ID: 20882098 [No Abstract] [Full Text] [Related]
91. Prophylactic treatment of chronic renal disease in patients undergoing peritoneal dialysis and colonized by Staphylococcus aureus: a systematic review and meta-analysis. Grothe C; Taminato M; Belasco A; Sesso R; Barbosa D BMC Nephrol; 2016 Aug; 17(1):115. PubMed ID: 27527505 [TBL] [Abstract][Full Text] [Related]
92. Treatment and outcome of peritonitis in automated peritoneal dialysis, using a once-daily cefazolin-based regimen. Fielding RE; Clemenger M; Goldberg L; Brown EA Perit Dial Int; 2002; 22(3):345-9. PubMed ID: 12227392 [TBL] [Abstract][Full Text] [Related]
97. Pharmacokinetics of Intraperitoneal Cefalothin and Cefazolin in Patients Being Treated for Peritoneal Dialysis-Associated Peritonitis. Roberts DM; Ranganathan D; Wallis SC; Varghese JM; Kark A; Lipman J; Roberts JA Perit Dial Int; 2016; 36(4):415-20. PubMed ID: 26764340 [TBL] [Abstract][Full Text] [Related]
98. Exit site and tunnel infections in children on chronic peritoneal dialysis: findings from the Standardizing Care to Improve Outcomes in Pediatric End Stage Renal Disease (SCOPE) Collaborative. Swartz SJ; Neu A; Skversky Mason A; Richardson T; Rodean J; Lawlor J; Warady B; Somers MJG Pediatr Nephrol; 2018 Jun; 33(6):1029-1035. PubMed ID: 29480421 [TBL] [Abstract][Full Text] [Related]
99. Staphylococcus aureus nasal carriage in children receiving long-term peritoneal dialysis. Kingwatanakul P; Warady BA Adv Perit Dial; 1997; 13():281-4. PubMed ID: 9360700 [TBL] [Abstract][Full Text] [Related]
100. Identification of Targets for Prevention of Peritoneal Catheter Tunnel and Exit-Site Infections in Low Incidence Settings. Santos C; Pérez-Fontán M; Rodríguez-Carmona A; Calvo-Rodríguez M; López-Muñiz A; López-Calviño B; García-Falcón T Perit Dial Int; 2016; 36(1):43-51. PubMed ID: 25292406 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]